IONS

Ionis Pharmaceuticals Inc.

Price

$60.80

return (12m)

43.13%

p/e

-16.37

p/bv

21.06

DIVIDEND YIELD

0.00%

IONS price

Ionis Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IONS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

14.49%

3 months

-19.77%

1 year

43.13%

2 years

27.62%

5 years

55.78%

10 years

79.51%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals IONS

Valuation

P/E

-16.37

Sector -4.38

Industry -4.38

P/BV

21.06

Sector 2.02

Industry 2.02

P/Revenue (PSR)

10.60

Sector -4.40

Industry -4.40

EV/EBITDA

-81.05

Sector -263.09

Industry -263.09

EV/EBIT

-81.05

Sector -702.90

Industry -702.90

P/EBITDA

-19.51

Sector -4.39

Industry -4.39

P/EBIT

-19.04

Sector -4.73

Industry -4.73

P/Total Assets

3.09

Sector 1.49

Industry 1.49

P/Net Current Assets

-147.09

Sector -11.70

Industry -11.70

P/Working Capital

6.51

Sector -3.19

Industry -3.19

EPS

-3.43

Sector -2.14

Industry -2.14

BVPS

2.67

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

98.14%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-35.82%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-35.82%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-68.03%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-64.76%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.09

Sector 0.03

Industry 0.03

Profitability

ROE

-128.64%

Sector -65.14%

Industry -65.14%

ROA

-18.90%

Sector -65.53%

Industry -65.53%

ROIC

-25.25%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.33

Sector 2.90

Industry 2.90

Net Debt / EBITDA

15.48

Sector -6.07

Industry -6.07

Net Debt / EBIT

15.48

Sector -8.26

Industry -8.26

Net Debt / Equity

-3.38

Sector -1.07

Industry -1.07

Gross Debt / Equity

1.29

Sector -0.05

Industry -0.05

Equity/Assets

0.15

Sector 0.41

Industry 0.41

Liabilities/Assets

0.85

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

1.52%

Sector -

Industry -

5Y Earnings CAGR

81.66%

Sector -

Industry -

Fundamentals IONS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IONS Ionis Pharmaceuticals Inc.	$60.80	40.00%	0.00%	-16.37	21.06	-128.64%	-64.76%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IONS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ionis Pharmaceuticals

Ionis Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

35 years

Founded: 1991

1991

Time since IPO - 35 years

817

Employees

Ionis Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $9.27 billion, with shareholders equity totaling $440.00 million.

The company employs approximately 817 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ionis Pharmaceuticals Inc. reported $874.05 million in revenue, generating net income of $-566.00 million.

Key financial metrics include a P/E ratio of -16.37, a price-to-book (P/B) ratio of 21.06, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IONS.

Market cap

$9.27 billion

Net worth

$440.00 million

$440,000,000.00

Assets

$3.00 billion

$2,995,000,000.00

Total Shares Outstanding

165.00 million

165,000,000

Average Daily Trading Volume

$3.14 million

$3,135,468.44

Sector

Health Care

Industry

Biotechnology

IONS

IONS revenue and profits

Financial Results IONS

DRAG THE FRAME TO SEE MORE DATA

IONS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Ionis Pharmaceuticals (IONS) today?

A cotação de Ionis Pharmaceuticals (IONS) hoje está em US$ 60.80, com uma variação de 43.13% em relação ao último ano. A cotação de Ionis Pharmaceuticals (IONS) iniciou o ano negociando na casa dos US$ 79.11 e hoje está em US$ 60.80. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Ionis Pharmaceuticals (IONS) e dados de ações do Ibovespa e mercados internacionais.

Quando Ionis Pharmaceuticals (IONS) paga dividendos?

Ionis Pharmaceuticals (IONS) não distribuiu dividendos no último ano.

Is Ionis Pharmaceuticals (IONS) a good investment?

Atualmente, Ionis Pharmaceuticals (IONS) está cotada a US$ 60.80, com um P/L de -16.37, representando um desvio de -2,037% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 43.13 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 43.13%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ionis Pharmaceuticals (IONS) stock?

Investir em ações de Ionis Pharmaceuticals (IONS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Ionis Pharmaceuticals (IONS) yield today?

A rentabilidade de Ionis Pharmaceuticals (IONS) foi de 14.49% no último mês, 43.13% no último ano e 55.78% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Ionis Pharmaceuticals (IONS) hoje, o investimento total seria de US$ 6,080.00, com base na cotação atual de US$ 60.80.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 8,702.30
Em 5 anos: US$ 9,471.42
Em 10 anos: US$ 10,914.21

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IONS

Ionis Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IONS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IONS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ionis Pharmaceuticals

Ionis Pharmaceuticals Inc.

United States

35 years

1991

817

PROFIT X PRICE IONS

Financial Results IONS

IONS cash flow

Asset, Revenue and Profit Growth - IONS

IONS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions